Pacira BioSciences (PCRX) Inventory Average (2011 - 2026)
Pacira BioSciences (PCRX) posted quarterly Inventory Average of $151.6 million for Q1 2026, up 17.06% year-over-year from $129.5 million in Q1 2025, and down 2.35% quarter-over-quarter from $155.3 million in Q4 2025.
Pacira BioSciences (PCRX) Inventory Average (2011 - 2026) Analysis & Trends
Pacira BioSciences' Inventory Average history runs 16 years deep, the most recent figure standing at $151.6 million for Q1 2026.
- In Q1 2026, Inventory Average rose 17.06% year-over-year to $151.6 million; the TTM figure through Mar 2026 stood at $151.6 million (up 17.06% YoY), while the FY2025 annual figure was $139.1 million, up 21.12% from the prior year.
- Inventory Average for Q1 2026 stood at $151.6 million, down from $155.3 million in the prior quarter.
- The five-year high for Inventory Average was $155.3 million in Q4 2025, with the low at $92.6 million in Q2 2023.
- The 5-year median for Inventory Average is $101.1 million (2022), against an average of $114.0 million.
- The sharpest annual moves came in 2022 and 2023: Inventory Average soared 57.27% in 2022, then decreased 9.37% in 2023.
- Pacira BioSciences' Inventory Average stood at $96.4 million in 2022, then climbed by 4.15% to $100.4 million in 2023, then increased by 18.06% to $118.6 million in 2024, then jumped by 30.95% to $155.3 million in 2025, then dropped by 2.35% to $151.6 million in 2026.
- Business Quant data shows PCRX's Inventory Average at $151.6 million in Q1 2026, $155.3 million in Q4 2025, and $152.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | 1.41 Bn |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 3.20 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 2.56 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 8.99 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 186.05 Mn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 3.93 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 84.35 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1.74 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 824.00 Mn |
| 10 | Pacira BioSciences | 945.51 Mn | 694.48 Mn | 148.24 Mn | 142.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 142.47 Mn |
| Mar 31, 2026 | 151.62 Mn |
| Dec 31, 2025 | 155.27 Mn |
| Sep 30, 2025 | 152.92 Mn |
| Jun 30, 2025 | 140.96 Mn |
| Mar 31, 2025 | 129.52 Mn |
| Dec 31, 2024 | 118.57 Mn |
| Sep 30, 2024 | 107.65 Mn |
| Jun 30, 2024 | 100.11 Mn |
| Mar 31, 2024 | 100.57 Mn |
| Dec 31, 2023 | 100.44 Mn |
| Sep 30, 2023 | 94.33 Mn |
| Jun 30, 2023 | 92.55 Mn |
| Mar 31, 2023 | 94.52 Mn |
| Dec 31, 2022 | 96.43 Mn |
| Sep 30, 2022 | 98.69 Mn |
| Jun 30, 2022 | 102.13 Mn |
| Mar 31, 2022 | 101.11 Mn |
| Dec 31, 2021 | 82.88 Mn |
| Sep 30, 2021 | 66.24 Mn |